| . | N = 6 . | Mean . | Median . | Range . |
|---|---|---|---|---|
| Gender (male/female) | 3/3 | |||
| BSA (m2) | 1.3 ± 0.2 | 1.4 | 0.7–1.7 | |
| Age at PVR (years) | 13.0 ± 2.3 | 12.2 | 6.9–20.1 | |
| Age at ToF repair (months) | 3.0 ± 0.6 | 2 | 1–5 | |
| Time to PVR (years) | 13.8 ± 2.6 | 12.5 | 6.9–19.8 | |
| NYHA class II–III | 4/6 | |||
| SR, complete RBBB (EKG) | 4/6 | |||
| QRS duration (ms) | 156.5 ± 8.7 | 162 | 128–174 | |
| Severe PR (ECHO) | 5/6 | |||
| Preoperative CMR | ||||
| RVEDVi (ml/m2) | 115.6 ± 16.2 | 108.5 | 62.5–183.0 | |
| RVESVi (ml/m2) | 61.5 ± 14.6 | 53.7 | 12.5–104.0 | |
| RVEF (%) | 55.1 ± 5.5 | 53.8 | 42.0–79.0 | |
| PR fraction (%) | 49.0 ± 6.9 | 49.0 | 22.0–73.0 | |
| LVEF (%) | 56.0 ± 1.7 | 54.5 | 51.0–62.0 |
| . | N = 6 . | Mean . | Median . | Range . |
|---|---|---|---|---|
| Gender (male/female) | 3/3 | |||
| BSA (m2) | 1.3 ± 0.2 | 1.4 | 0.7–1.7 | |
| Age at PVR (years) | 13.0 ± 2.3 | 12.2 | 6.9–20.1 | |
| Age at ToF repair (months) | 3.0 ± 0.6 | 2 | 1–5 | |
| Time to PVR (years) | 13.8 ± 2.6 | 12.5 | 6.9–19.8 | |
| NYHA class II–III | 4/6 | |||
| SR, complete RBBB (EKG) | 4/6 | |||
| QRS duration (ms) | 156.5 ± 8.7 | 162 | 128–174 | |
| Severe PR (ECHO) | 5/6 | |||
| Preoperative CMR | ||||
| RVEDVi (ml/m2) | 115.6 ± 16.2 | 108.5 | 62.5–183.0 | |
| RVESVi (ml/m2) | 61.5 ± 14.6 | 53.7 | 12.5–104.0 | |
| RVEF (%) | 55.1 ± 5.5 | 53.8 | 42.0–79.0 | |
| PR fraction (%) | 49.0 ± 6.9 | 49.0 | 22.0–73.0 | |
| LVEF (%) | 56.0 ± 1.7 | 54.5 | 51.0–62.0 |
BSA: body surface area; CMR: cardiac magnetic resonance; LVEF: left ventricular ejection fraction; NYHA: New York Heart Association; PR: pulmonary regurgitation; PVR: pulmonary valve replacement; RBBB: right bundle branch block; RVEDVi: right ventricular end-diastolic volume index; RVEF: right ventricular ejection fraction; RVESVi: right ventricular end-systolic volume index; SR: sinus rhythm; ToF: tetralogy of Fallot.
| . | N = 6 . | Mean . | Median . | Range . |
|---|---|---|---|---|
| Gender (male/female) | 3/3 | |||
| BSA (m2) | 1.3 ± 0.2 | 1.4 | 0.7–1.7 | |
| Age at PVR (years) | 13.0 ± 2.3 | 12.2 | 6.9–20.1 | |
| Age at ToF repair (months) | 3.0 ± 0.6 | 2 | 1–5 | |
| Time to PVR (years) | 13.8 ± 2.6 | 12.5 | 6.9–19.8 | |
| NYHA class II–III | 4/6 | |||
| SR, complete RBBB (EKG) | 4/6 | |||
| QRS duration (ms) | 156.5 ± 8.7 | 162 | 128–174 | |
| Severe PR (ECHO) | 5/6 | |||
| Preoperative CMR | ||||
| RVEDVi (ml/m2) | 115.6 ± 16.2 | 108.5 | 62.5–183.0 | |
| RVESVi (ml/m2) | 61.5 ± 14.6 | 53.7 | 12.5–104.0 | |
| RVEF (%) | 55.1 ± 5.5 | 53.8 | 42.0–79.0 | |
| PR fraction (%) | 49.0 ± 6.9 | 49.0 | 22.0–73.0 | |
| LVEF (%) | 56.0 ± 1.7 | 54.5 | 51.0–62.0 |
| . | N = 6 . | Mean . | Median . | Range . |
|---|---|---|---|---|
| Gender (male/female) | 3/3 | |||
| BSA (m2) | 1.3 ± 0.2 | 1.4 | 0.7–1.7 | |
| Age at PVR (years) | 13.0 ± 2.3 | 12.2 | 6.9–20.1 | |
| Age at ToF repair (months) | 3.0 ± 0.6 | 2 | 1–5 | |
| Time to PVR (years) | 13.8 ± 2.6 | 12.5 | 6.9–19.8 | |
| NYHA class II–III | 4/6 | |||
| SR, complete RBBB (EKG) | 4/6 | |||
| QRS duration (ms) | 156.5 ± 8.7 | 162 | 128–174 | |
| Severe PR (ECHO) | 5/6 | |||
| Preoperative CMR | ||||
| RVEDVi (ml/m2) | 115.6 ± 16.2 | 108.5 | 62.5–183.0 | |
| RVESVi (ml/m2) | 61.5 ± 14.6 | 53.7 | 12.5–104.0 | |
| RVEF (%) | 55.1 ± 5.5 | 53.8 | 42.0–79.0 | |
| PR fraction (%) | 49.0 ± 6.9 | 49.0 | 22.0–73.0 | |
| LVEF (%) | 56.0 ± 1.7 | 54.5 | 51.0–62.0 |
BSA: body surface area; CMR: cardiac magnetic resonance; LVEF: left ventricular ejection fraction; NYHA: New York Heart Association; PR: pulmonary regurgitation; PVR: pulmonary valve replacement; RBBB: right bundle branch block; RVEDVi: right ventricular end-diastolic volume index; RVEF: right ventricular ejection fraction; RVESVi: right ventricular end-systolic volume index; SR: sinus rhythm; ToF: tetralogy of Fallot.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
